Background: Entrapment of small intestine into the epiploic foramen (EEF) represents an important cause of strangulating small intestinal obstruction (SSI). Both the short and long-term prognosis seem to be less favourable than for other types of SSI.
PEROPERATIVE MESH OBLITERATION OF EPIPLOIC FORAMEN TO PREVENT RECURRENT ENTRAPMENT
Grulke S., Salciccia A., de la Rebi ere de Pouyade G., Sandersen C., Caudron I. and Serteyn D. Equine Clinic, Department of Clinical Sciences, B41. FARAH, Universit e de Li ege, Avenue de Cureghem 5D, 4000 Liege, Belgium. Email: sgrulke@ulg.ac.be. Background: Entrapment of small intestine into the epiploic foramen (EEF) represents an important cause of strangulating small intestinal obstruction (SSI). Both the short and long-term prognosis seem to be less favourable than for other types of SSI.
Objectives: The aim of the study is to report a technique of mesh closure of the epiploic foramen (EF) during emergency coeliotomy and to report short-and long-term outcome of horses operated for EEF with mesh closure.
Methods: A polypropylene net was rolled and fixed by one stitch to obtain a cone coated with a piece of resected omentum and inserted into the EF from the medial to lateral side at the end of the laparotomy.
Results: 12 horses with a mean age of 10 years suffering from EEF (one horse 3rd time within 6 months) underwent surgery for correction of entrapment and mesh closure. Post-operative complications (mainly paralytic ileus) occurred in 5 of the 12 horses. One horse was euthanized due to recurrence of severe colic (volvulus). Necropsy confirmed the mesh remaining in the EF. Long-term follow-up was available in 9 horses and the outcome was favourable in 9 horses. One horse had an exploratory coelioscopy 5 months after surgery (other cause of recurrent colic) and fibrous closure of the EF was confirmed. One horse was euthanized 3.5 years after mesh placement due to unrelated reasons and the fibrous integration of the mesh in the EF was shown at necropsy. Background: Clinical endotoxemia following small intestinal strangulating obstruction (SISO) is associated with an increased risk of death. Non-steroidal anti-inflammatory drugs (NSAIDs) treat endotoxic shock by blocking prostanoid production by cyclooxygenases (COX) -1 and -2, which can be selectively inhibited. COX-1 is expressed constitutively and is known to promote gut barrier function, whereas COX-2 is induced in inflammation and contributes to signs of endotoxemia. In preclinical SISO models, barrier recovery occurred faster with COX-1-sparing NSAIDs as compared to non-selective NSAIDs.
Conclusion
Objectives: We hypothesized that treatment of post-surgical SISO horses with either firocoxib (COX-2-selective) or flunixin (nonselective) would result in effective pain control while endotoxemia would be reduced in the firocoxib group.
Methods: Post-operative SISO patients were administered either flunixin (1.1 mg/kg IV q12 h) or firocoxib (0.3 mg/kg IV loading dose; 0.1 mg/kg IV q24 h) in a blinded randomized control trial.
Results: In 46 cases, we observed no significant difference in pain control between the two groups (P = 0.438). COX selectivity was confirmed by significant suppression of plasma thromboxane B 2 in the flunixin group (COX-1 inhibition, P = 0.012), whereas both drugs equally suppressed PGE 2 production (COX-2 inhibition, P = 0.190). The flunixin group had a 2-fold relative risk of elevated plasma sCD14, a marker of endotoxemia, although this was not statistically significant (relative risk 1.94, confidence interval 0.462-7.38). However, there was no significant difference in TNFa between groups (P = 0.398).
Conclusions: In SISO patients, flunixin or firocoxib effectively controls postoperative pain, but firocoxib may be associated with a reduced risk of clinical endotoxemia. The trial is currently receiving additional cases to further assess endotoxemia.
